Package 61755-054-01

Brand: lynozyfic

Generic: linvoseltamab-gcpt
NDC Package

Package Facts

Identity

Package NDC 61755-054-01
Digits Only 6175505401
Product NDC 61755-054
Product ID 61755-054_d82c287f-a94e-4831-9991-4742cdd17348
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)

Marketing

Marketing Status
Marketed Since 2025-07-02
Brand lynozyfic
Generic linvoseltamab-gcpt
Sample Package No

Linked Drug Pages (1)

LYNOZYFIC ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d82c287f-a94e-4831-9991-4742cdd17348", "openfda": {"unii": ["M3CPC50MZS"], "rxcui": ["2719483", "2719490", "2719494", "2719497"], "spl_set_id": ["e9fd0739-1b3f-4b8b-824a-1f0a902384d3"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01)  / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)", "package_ndc": "61755-054-01", "marketing_start_date": "20250702"}], "brand_name": "LYNOZYFIC", "product_id": "61755-054_d82c287f-a94e-4831-9991-4742cdd17348", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "product_ndc": "61755-054", "generic_name": "linvoseltamab-gcpt", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LYNOZYFIC", "active_ingredients": [{"name": "LINVOSELTAMAB", "strength": "5 mg/2.5mL"}], "application_number": "BLA761400", "marketing_category": "BLA", "marketing_start_date": "20250702", "listing_expiration_date": "20261231"}